Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis
Clinical trial NCT04287608 · COMPLETED
Trial details
- NCT number
- NCT04287608
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-10
- Primary completion
- 2023-03-29
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.